489 related articles for article (PubMed ID: 15875089)
21. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
Rosell R; Monzó M; Pifarré A; Ariza A; Sánchez JJ; Moreno I; Maurel J; López MP; Abad A; de Anta JM
Clin Cancer Res; 1996 Jun; 2(6):1083-6. PubMed ID: 9816271
[TBL] [Abstract][Full Text] [Related]
22. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].
Wang L; Wang G; Xia X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):236-9. PubMed ID: 11326973
[TBL] [Abstract][Full Text] [Related]
23. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591
[TBL] [Abstract][Full Text] [Related]
24. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
Camps C; Sirera R; Bremnes R; Blasco A; Sancho E; Bayo P; Safont MJ; Sánchez JJ; Tarón M; Rosell R
Lung Cancer; 2005 Dec; 50(3):339-46. PubMed ID: 16139926
[TBL] [Abstract][Full Text] [Related]
25. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
26. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
Cui Q; Wang Z; Chen J; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
[TBL] [Abstract][Full Text] [Related]
27. Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.
Urban T; Ricci S; Danel C; Antoine M; Kambouchner M; Godard V; Lacave R; Bernaudin JF
Br J Cancer; 2000 Jan; 82(2):412-7. PubMed ID: 10646897
[TBL] [Abstract][Full Text] [Related]
28. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
29. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
30. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
[TBL] [Abstract][Full Text] [Related]
31. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of RAS oncogene mutation in head and neck carcinomas.
Anderson JA; Irish JC; Ngan BY
J Otolaryngol; 1992 Oct; 21(5):321-6. PubMed ID: 1361585
[TBL] [Abstract][Full Text] [Related]
33. High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.
Scott FM; Modali R; Lehman TA; Seddon M; Kelly K; Dempsey EC; Wilson V; Tockman MS; Mulshine JL
Clin Cancer Res; 1997 Mar; 3(3):479-82. PubMed ID: 9815708
[TBL] [Abstract][Full Text] [Related]
34. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer.
Sekine I; Takami S; Guang SG; Yokose T; Kodama T; Nishiwaki Y; Kinoshita M; Matsumoto H; Ogura T; Nagai K
Oncol Rep; 1998; 5(2):351-4. PubMed ID: 9468555
[TBL] [Abstract][Full Text] [Related]
35. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.
Mills NE; Fishman CL; Scholes J; Anderson SE; Rom WN; Jacobson DR
J Natl Cancer Inst; 1995 Jul; 87(14):1056-60. PubMed ID: 7616596
[TBL] [Abstract][Full Text] [Related]
36. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
[TBL] [Abstract][Full Text] [Related]
37. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
38. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y
Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
[TBL] [Abstract][Full Text] [Related]
40. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
Mitsudomi T; Steinberg SM; Oie HK; Mulshine JL; Phelps R; Viallet J; Pass H; Minna JD; Gazdar AF
Cancer Res; 1991 Sep; 51(18):4999-5002. PubMed ID: 1654209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
